25 XP   0   0   10

Pasithea Therapeutics Corp
Buy, Hold or Sell?

Let's analyse Pasithea together

PenkeI guess you are interested in Pasithea Therapeutics Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pasithea Therapeutics Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pasithea Therapeutics Corp

I send you an email if I find something interesting about Pasithea Therapeutics Corp.

Quick analysis of Pasithea (30 sec.)










What can you expect buying and holding a share of Pasithea? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.13
Expected worth in 1 year
$0.49
How sure are you?
36.4%

+ What do you gain per year?

Total Gains per Share
$-0.63
Return On Investment
-8.9%

For what price can you sell your share?

Current Price per Share
$7.15
Expected price per share
$5.26 - $11.60
How sure are you?
50%

1. Valuation of Pasithea (5 min.)




Live pricePrice per Share (EOD)

$7.15

2. Growth of Pasithea (5 min.)




Is Pasithea growing?

Current yearPrevious yearGrowGrow %
How rich?$28.3m$49.9m-$13.5m-37.1%

How much money is Pasithea making?

Current yearPrevious yearGrowGrow %
Making money-$71.6m-$1.6m-$70m-97.8%
Net Profit Margin-405.3%-2,820.6%--

How much money comes from the company's main activities?

3. Financial Health of Pasithea (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#560 / 1031

Most Revenue
#656 / 1031

Most Profit
#960 / 1031

Most Efficient
#735 / 1031

What can you expect buying and holding a share of Pasithea? (5 min.)

Welcome investor! Pasithea's management wants to use your money to grow the business. In return you get a share of Pasithea.

What can you expect buying and holding a share of Pasithea?

First you should know what it really means to hold a share of Pasithea. And how you can make/lose money.

Speculation

The Price per Share of Pasithea is $7.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pasithea.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pasithea, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.13. Based on the TTM, the Book Value Change Per Share is $-0.16 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pasithea.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.14-2.0%-0.15-2.0%-0.07-1.0%-0.10-1.5%-0.10-1.5%
Usd Book Value Change Per Share-0.23-3.3%-0.16-2.2%-0.02-0.3%0.101.4%0.101.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.23-3.3%-0.16-2.2%-0.02-0.3%0.101.4%0.101.4%
Usd Price Per Share0.48-0.50-1.34-0.94-0.94-
Price to Earnings Ratio-0.84--0.85--0.37--0.85--0.85-
Price-to-Total Gains Ratio-2.05--3.93-10.07-2.92-2.92-
Price to Book Ratio0.43-0.35-0.53-0.47-0.47-
Price-to-Total Gains Ratio-2.05--3.93-10.07-2.92-2.92-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.15
Number of shares139
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.160.10
Usd Total Gains Per Share-0.160.10
Gains per Quarter (139 shares)-22.0614.25
Gains per Year (139 shares)-88.2257.00
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-88-9805747
20-176-1860114104
30-265-2740171161
40-353-3620228218
50-441-4500285275
60-529-5380342332
70-618-6260399389
80-706-7140456446
90-794-8020513503
100-882-8900570560

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.010.00.09.1%1.010.00.09.1%1.010.00.09.1%1.010.00.09.1%
Book Value Change Per Share0.04.00.00.0%4.07.00.036.4%4.07.00.036.4%4.07.00.036.4%4.07.00.036.4%
Dividend per Share0.00.04.00.0%0.00.011.00.0%0.00.011.00.0%0.00.011.00.0%0.00.011.00.0%
Total Gains per Share0.04.00.00.0%4.07.00.036.4%4.07.00.036.4%4.07.00.036.4%4.07.00.036.4%

Fundamentals of Pasithea

About Pasithea Therapeutics Corp

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for Central Nervous System disorders, RASopathies, and other diseases. It operates through two segments, Therapeutics and Clinics. The company provides business support services to anti-depression clinics, entities, and registered healthcare providers. Its lead product candidate PAS-004, a next-generation mitogen-activated protein kinase, or MEK inhibitor designed to be macrocyclic for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 and Noonan syndrome, as well as lamin A/C cardiomyopathy and oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; PAS-002, for the treatment multiple sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Fundamental data was last updated by Penke on 2024-03-25 07:38:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pasithea Therapeutics Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pasithea earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pasithea to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pasithea Therapeutics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-405.3%+405.3%
TTM-405.3%YOY-2,820.6%+2,415.3%
TTM-405.3%5Y-1,173.1%+767.8%
5Y-1,173.1%10Y-1,173.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--171.8%+171.8%
TTM-405.3%-205.8%-199.5%
YOY-2,820.6%-262.1%-2,558.5%
5Y-1,173.1%-455.6%-717.5%
10Y-1,173.1%-589.0%-584.1%
1.1.2. Return on Assets

Shows how efficient Pasithea is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pasithea to the Biotechnology industry mean.
  • -11.8% Return on Assets means that Pasithea generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pasithea Therapeutics Corp:

  • The MRQ is -11.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -171.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.8%TTM-171.2%+159.4%
TTM-171.2%YOY-3.2%-168.0%
TTM-171.2%5Y-75.6%-95.6%
5Y-75.6%10Y-75.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.8%-12.5%+0.7%
TTM-171.2%-12.2%-159.0%
YOY-3.2%-11.2%+8.0%
5Y-75.6%-13.4%-62.2%
10Y-75.6%-14.7%-60.9%
1.1.3. Return on Equity

Shows how efficient Pasithea is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pasithea to the Biotechnology industry mean.
  • -12.7% Return on Equity means Pasithea generated $-0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pasithea Therapeutics Corp:

  • The MRQ is -12.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -183.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.7%TTM-183.9%+171.1%
TTM-183.9%YOY-3.4%-180.5%
TTM-183.9%5Y-88.6%-95.3%
5Y-88.6%10Y-88.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.7%-15.8%+3.1%
TTM-183.9%-15.7%-168.2%
YOY-3.4%-13.9%+10.5%
5Y-88.6%-18.3%-70.3%
10Y-88.6%-19.2%-69.4%

1.2. Operating Efficiency of Pasithea Therapeutics Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pasithea is operating .

  • Measures how much profit Pasithea makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pasithea to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pasithea Therapeutics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-527.7%+527.7%
TTM-527.7%YOY-18,097.2%+17,569.5%
TTM-527.7%5Y-6,772.7%+6,245.0%
5Y-6,772.7%10Y-6,772.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM-527.7%-210.1%-317.6%
YOY-18,097.2%-279.7%-17,817.5%
5Y-6,772.7%-459.9%-6,312.8%
10Y-6,772.7%-596.9%-6,175.8%
1.2.2. Operating Ratio

Measures how efficient Pasithea is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pasithea Therapeutics Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.530-5.530
TTM5.530YOY139.043-133.514
TTM5.5305Y52.572-47.042
5Y52.57210Y52.5720.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.861-2.861
TTM5.5303.193+2.337
YOY139.0433.615+135.428
5Y52.5725.560+47.012
10Y52.5727.396+45.176

1.3. Liquidity of Pasithea Therapeutics Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pasithea is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.16 means the company has $10.16 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pasithea Therapeutics Corp:

  • The MRQ is 10.162. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.888. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.162TTM13.888-3.725
TTM13.888YOY79.297-65.409
TTM13.8885Y38.124-24.236
5Y38.12410Y38.1240.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.1623.986+6.176
TTM13.8884.440+9.448
YOY79.2975.552+73.745
5Y38.1246.158+31.966
10Y38.1246.492+31.632
1.3.2. Quick Ratio

Measures if Pasithea is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pasithea to the Biotechnology industry mean.
  • A Quick Ratio of 9.63 means the company can pay off $9.63 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pasithea Therapeutics Corp:

  • The MRQ is 9.628. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 13.389. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.628TTM13.389-3.761
TTM13.389YOY78.241-64.852
TTM13.3895Y37.380-23.991
5Y37.38010Y37.3800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.6283.638+5.990
TTM13.3894.168+9.221
YOY78.2415.515+72.726
5Y37.3806.012+31.368
10Y37.3806.209+31.171

1.4. Solvency of Pasithea Therapeutics Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pasithea assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pasithea to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.07 means that Pasithea assets are financed with 7.4% credit (debt) and the remaining percentage (100% - 7.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pasithea Therapeutics Corp:

  • The MRQ is 0.074. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.068. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.074TTM0.068+0.007
TTM0.068YOY0.036+0.032
TTM0.0685Y0.121-0.054
5Y0.12110Y0.1210.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0740.335-0.261
TTM0.0680.330-0.262
YOY0.0360.267-0.231
5Y0.1210.367-0.246
10Y0.1210.378-0.257
1.4.2. Debt to Equity Ratio

Measures if Pasithea is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pasithea to the Biotechnology industry mean.
  • A Debt to Equity ratio of 8.0% means that company has $0.08 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pasithea Therapeutics Corp:

  • The MRQ is 0.080. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.072. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.080TTM0.072+0.008
TTM0.072YOY0.037+0.035
TTM0.0725Y0.177-0.105
5Y0.17710Y0.1770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0800.376-0.296
TTM0.0720.398-0.326
YOY0.0370.334-0.297
5Y0.1770.429-0.252
10Y0.1770.476-0.299

2. Market Valuation of Pasithea Therapeutics Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pasithea generates.

  • Above 15 is considered overpriced but always compare Pasithea to the Biotechnology industry mean.
  • A PE ratio of -0.84 means the investor is paying $-0.84 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pasithea Therapeutics Corp:

  • The EOD is -12.450. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.836. Based on the earnings, the company is expensive. -2
  • The TTM is -0.853. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.450MRQ-0.836-11.614
MRQ-0.836TTM-0.853+0.017
TTM-0.853YOY-0.373-0.480
TTM-0.8535Y-0.852-0.002
5Y-0.85210Y-0.8520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.450-2.643-9.807
MRQ-0.836-2.418+1.582
TTM-0.853-2.742+1.889
YOY-0.373-4.123+3.750
5Y-0.852-6.257+5.405
10Y-0.852-6.478+5.626
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pasithea Therapeutics Corp:

  • The EOD is -17.088. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.147. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.867. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.088MRQ-1.147-15.940
MRQ-1.147TTM-0.867-0.280
TTM-0.867YOY-2.360+1.493
TTM-0.8675Y-2.302+1.434
5Y-2.30210Y-2.3020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-17.088-3.244-13.844
MRQ-1.147-2.939+1.792
TTM-0.867-3.478+2.611
YOY-2.360-5.592+3.232
5Y-2.302-8.473+6.171
10Y-2.302-8.881+6.579
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pasithea is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.43 means the investor is paying $0.43 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pasithea Therapeutics Corp:

  • The EOD is 6.340. Based on the equity, the company is overpriced. -1
  • The MRQ is 0.426. Based on the equity, the company is cheap. +2
  • The TTM is 0.354. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.340MRQ0.426+5.915
MRQ0.426TTM0.354+0.071
TTM0.354YOY0.533-0.179
TTM0.3545Y0.473-0.119
5Y0.47310Y0.4730.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.3402.124+4.216
MRQ0.4262.041-1.615
TTM0.3542.118-1.764
YOY0.5332.915-2.382
5Y0.4733.682-3.209
10Y0.4734.114-3.641
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Pasithea Therapeutics Corp.

3.1. Institutions holding Pasithea Therapeutics Corp

Institutions are holding 23.882% of the shares of Pasithea Therapeutics Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Geode Capital Management, LLC0.600501251232687527.3542
2023-09-30Renaissance Technologies Corp0.1481030864-3863-11.1239
2023-09-30Tower Research Capital LLC0.05990.00021249010.008
2023-09-30Royal Bank of Canada0.0240500000
2023-09-30JPMorgan Chase & Co0.01440300000
2023-09-30Wells Fargo & Co0.000701513226.8908
2023-12-31NAPLES GLOBAL ADVISORS, LLC000-10620-100
2023-09-30State Street Corporation000-23647-100
2023-12-31Susquehanna International Group, LLP000-38568-100
2023-09-30JANE STREET GROUP, LLC000-14862-100
2023-12-31UBS Group AG000-83-100
2023-12-31Mark Sheptoff Financial Planning LLC000-3323-100
2023-09-30Vanguard Group Inc000-121007-100
2023-12-31Virtu Financial LLC000-15469-100
2023-12-31XTX Topco Ltd000-10726-100
2023-09-30HRT FINANCIAL LLC000-41133-100
Total 0.84760.0002176628-256393-145.2%

3.2. Funds holding Pasithea Therapeutics Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31NT Ext Equity Mkt Idx Fd - L0.22590.00034707437193376.4093
2024-01-31Fidelity Extended Market Index0.52660.0001548600
2023-12-31Northern Trust Extended Eq Market Idx0.01130.00032354-7527-76.1765
2024-01-31Fidelity Series Total Market Index0.09210960577150.6527
2024-01-31Spartan Total Market Index Pool E0.022022900
2024-01-31Spartan Extended Market Index Pool E0.01410.000114700
Total 0.8920.000856250+30243+53.8%

3.3. Insider Transactions

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-06-02Lawrence SteinmanBUY15008.6

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Pasithea Therapeutics Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.234-0.159-32%-0.019-92%0.103-329%0.103-329%
Book Value Per Share--1.1281.418-20%2.768-59%1.700-34%1.700-34%
Current Ratio--10.16213.888-27%79.297-87%38.124-73%38.124-73%
Debt To Asset Ratio--0.0740.068+10%0.036+108%0.121-38%0.121-38%
Debt To Equity Ratio--0.0800.072+11%0.037+115%0.177-55%0.177-55%
Dividend Per Share----0%-0%-0%-0%
Eps---0.144-0.145+1%-0.073-49%-0.105-27%-0.105-27%
Free Cash Flow Per Share---0.105-0.152+45%-0.148+41%-0.121+16%-0.121+16%
Free Cash Flow To Equity Per Share---0.282-0.227-19%0.663-142%0.531-153%0.531-153%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap7449084.500-62%12077277.12012717255.938-5%26364266.973-54%16686630.047-28%16686630.047-28%
Net Profit Margin----4.0530%-28.2060%-11.7310%-11.7310%
Operating Margin----5.2770%-180.9720%-67.7270%-67.7270%
Operating Ratio---5.530-100%139.043-100%52.572-100%52.572-100%
Pb Ratio6.340+93%0.4260.354+20%0.533-20%0.473-10%0.473-10%
Pe Ratio-12.450-1390%-0.836-0.853+2%-0.373-55%-0.852+2%-0.852+2%
Price Per Share7.150+93%0.4800.497-3%1.335-64%0.942-49%0.942-49%
Price To Free Cash Flow Ratio-17.088-1390%-1.147-0.867-24%-2.360+106%-2.302+101%-2.302+101%
Price To Total Gains Ratio-30.495-1390%-2.047-3.931+92%10.069-120%2.916-170%2.916-170%
Quick Ratio--9.62813.389-28%78.241-88%37.380-74%37.380-74%
Return On Assets---0.118-1.712+1353%-0.032-73%-0.756+542%-0.756+542%
Return On Equity---0.127-1.839+1344%-0.034-74%-0.886+596%-0.886+596%
Total Gains Per Share---0.234-0.159-32%-0.019-92%0.103-329%0.103-329%
Usd Book Value--28373606.00036399288.750-22%49915055.500-43%33009386.091-14%33009386.091-14%
Usd Book Value Change Per Share---0.234-0.159-32%-0.019-92%0.103-329%0.103-329%
Usd Book Value Per Share--1.1281.418-20%2.768-59%1.700-34%1.700-34%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.144-0.145+1%-0.073-49%-0.105-27%-0.105-27%
Usd Free Cash Flow---2632053.000-3894588.750+48%-3062530.000+16%-2659836.364+1%-2659836.364+1%
Usd Free Cash Flow Per Share---0.105-0.152+45%-0.148+41%-0.121+16%-0.121+16%
Usd Free Cash Flow To Equity Per Share---0.282-0.227-19%0.663-142%0.531-153%0.531-153%
Usd Market Cap7449084.500-62%12077277.12012717255.938-5%26364266.973-54%16686630.047-28%16686630.047-28%
Usd Price Per Share7.150+93%0.4800.497-3%1.335-64%0.942-49%0.942-49%
Usd Profit---3612590.000-71603257.500+1882%-1600070.250-56%-26874270.455+644%-26874270.455+644%
Usd Revenue---60178.000-100%65227.250-100%45601.909-100%45601.909-100%
Usd Total Gains Per Share---0.234-0.159-32%-0.019-92%0.103-329%0.103-329%
 EOD+3 -5MRQTTM+12 -19YOY+7 -245Y+11 -2010Y+11 -20

4.2. Fundamental Score

Let's check the fundamental score of Pasithea Therapeutics Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-12.450
Price to Book Ratio (EOD)Between0-16.340
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than19.628
Current Ratio (MRQ)Greater than110.162
Debt to Asset Ratio (MRQ)Less than10.074
Debt to Equity Ratio (MRQ)Less than10.080
Return on Equity (MRQ)Greater than0.15-0.127
Return on Assets (MRQ)Greater than0.05-0.118
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Pasithea Therapeutics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.204
Ma 20Greater thanMa 507.252
Ma 50Greater thanMa 1007.041
Ma 100Greater thanMa 2007.036
OpenGreater thanClose7.100
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets30,657
Total Liabilities2,284
Total Stockholder Equity28,374
 As reported
Total Liabilities 2,284
Total Stockholder Equity+ 28,374
Total Assets = 30,657

Assets

Total Assets30,657
Total Current Assets20,771
Long-term Assets9,886
Total Current Assets
Cash And Cash Equivalents 19,585
Net Receivables 95
Inventory 985
Other Current Assets 107
Total Current Assets  (as reported)20,771
Total Current Assets  (calculated)20,771
+/-0
Long-term Assets
Property Plant Equipment 524
Goodwill 1,263
Intangible Assets 8,099
Long-term Assets  (as reported)9,886
Long-term Assets  (calculated)9,886
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,044
Long-term Liabilities240
Total Stockholder Equity28,374
Total Current Liabilities
Short-term Debt 174
Other Current Liabilities 1,869
Total Current Liabilities  (as reported)2,044
Total Current Liabilities  (calculated)2,044
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt211
Long-term Liabilities  (as reported)240
Long-term Liabilities  (calculated)211
+/- 29
Total Stockholder Equity
Common Stock17
Retained Earnings -30,270
Accumulated Other Comprehensive Income -8
Other Stockholders Equity 58,634
Total Stockholder Equity (as reported)28,374
Total Stockholder Equity (calculated)28,374
+/-0
Other
Capital Stock17
Cash and Short Term Investments 19,585
Common Stock Shares Outstanding 25,161
Liabilities and Stockholders Equity 30,657
Net Debt -19,199
Net Invested Capital 28,374
Net Working Capital 18,727
Property Plant and Equipment Gross 543
Short Long Term Debt Total 385



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-09-30
> Total Assets 
0
1,140
925
21,042
53,321
51,079
53,028
49,608
45,180
42,045
38,149
30,657
30,65738,14942,04545,18049,60853,02851,07953,32121,0429251,1400
   > Total Current Assets 
0
1,140
925
21,034
53,300
50,950
48,614
44,469
34,077
31,113
28,037
20,771
20,77128,03731,11334,07744,46948,61450,95053,30021,0349251,1400
       Cash And Cash Equivalents 
0
1,071
569
20,565
52,967
50,321
47,940
42,398
33,147
29,914
26,648
19,585
19,58526,64829,91433,14742,39847,94050,32152,96720,5655691,0710
       Net Receivables 
0
0
0
0
0
0
47
0
302
16
123
95
9512316302047000000
       Other Current Assets 
0
69
356
469
334
629
80
866
628
263
452
107
10745226362886680629334469356690
   > Long-term Assets 
0
0
0
9
20
129
4,413
5,139
11,103
10,932
10,112
9,886
9,88610,11210,93211,1035,1394,413129209000
       Property Plant Equipment 
0
0
0
9
20
129
580
1,272
1,253
635
593
524
5245936351,2531,272580129209000
       Goodwill 
0
0
0
0
0
0
3,833
3,854
1,263
1,263
1,263
1,263
1,2631,2631,2631,2633,8543,833000000
       Intangible Assets 
0
0
0
0
0
0
0
13
8,587
8,414
8,256
8,099
8,0998,2568,4148,587130000000
> Total Liabilities 
0
239
455
4,567
1,900
1,101
1,554
2,819
2,682
2,910
2,559
2,284
2,2842,5592,9102,6822,8191,5541,1011,9004,5674552390
   > Total Current Liabilities 
0
239
455
528
447
434
950
1,514
1,878
2,122
2,229
2,044
2,0442,2292,1221,8781,5149504344475284552390
       Short-term Debt 
0
0
0
0
0
0
101
258
263
429
303
174
174303429263258101000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
264
133
0
0133264000000000
       Accounts payable 
0
239
455
528
447
434
849
1,256
1,614
1,448
1,926
0
01,9261,4481,6141,2568494344475284552390
       Other Current Liabilities 
0
239
455
528
447
434
849
1,256
1,614
1,693
1,926
1,869
1,8691,9261,6931,6141,2568494344475284552390
   > Long-term Liabilities 
0
0
0
4,039
1,453
668
604
1,306
804
788
330
240
2403307888041,3066046681,4534,039000
       Other Liabilities 
0
0
0
4,039
1,453
668
246
581
0
0
74
0
074005812466681,4534,039000
> Total Stockholder Equity
0
901
470
16,475
51,421
49,977
51,474
46,789
42,498
39,135
35,590
28,374
28,37435,59039,13542,49846,78951,47449,97751,42116,4754709010
   Common Stock
0
16
16
17
18
18
18
18
18
18
18
17
17181818181818181716160
   Retained Earnings Total Equity000000000000
   Accumulated Other Comprehensive Income -8-3-3-1-147-64-15-11-4-200
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
1,475
1,775
19,307
53,628
53,764
57,967
57,951
61,838
62,015
62,233
58,634
58,63462,23362,01561,83857,95157,96753,76453,62819,3071,7751,4750



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue487
Cost of Revenue--
Gross Profit-487
 
Operating Income (+$)
Gross Profit-
Operating Expense-17,587
Operating Income-17,101-17,587
 
Operating Expense (+$)
Research Development6,136
Selling General Administrative11,338
Selling And Marketing Expenses-
Operating Expense17,58717,474
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-242
Net Interest Income242
 
Pretax Income (+$)
Operating Income-17,101
Net Interest Income242
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-16,738-17,221
EBIT - interestExpense = 0
-16,031
-16,031
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--16,738
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-16,738
Tax Provision-0
Net Income From Continuing Ops-16,738-16,738
Net Income-16,031
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net120-242
 

Technical Analysis of Pasithea
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pasithea. The general trend of Pasithea is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pasithea's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pasithea Therapeutics Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.13 < 9.4 < 11.60.

The bearish price targets are: 5.705 > 5.26.

Tweet this
Pasithea Therapeutics Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pasithea Therapeutics Corp. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pasithea Therapeutics Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pasithea Therapeutics Corp. The current macd is -0.02305189.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pasithea price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pasithea. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pasithea price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Pasithea Therapeutics Corp Daily Moving Average Convergence/Divergence (MACD) ChartPasithea Therapeutics Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pasithea Therapeutics Corp. The current adx is 14.82.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Pasithea shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Pasithea Therapeutics Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pasithea Therapeutics Corp. The current sar is 7.810238.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pasithea Therapeutics Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pasithea Therapeutics Corp. The current rsi is 50.20. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Pasithea Therapeutics Corp Daily Relative Strength Index (RSI) ChartPasithea Therapeutics Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pasithea Therapeutics Corp. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pasithea price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pasithea Therapeutics Corp Daily Stochastic Oscillator ChartPasithea Therapeutics Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pasithea Therapeutics Corp. The current cci is -39.22524659.

Pasithea Therapeutics Corp Daily Commodity Channel Index (CCI) ChartPasithea Therapeutics Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pasithea Therapeutics Corp. The current cmo is 1.01265018.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Pasithea Therapeutics Corp Daily Chande Momentum Oscillator (CMO) ChartPasithea Therapeutics Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pasithea Therapeutics Corp. The current willr is -43.86514601.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Pasithea is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Pasithea Therapeutics Corp Daily Williams %R ChartPasithea Therapeutics Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pasithea Therapeutics Corp. The current atr is 0.38439692.

Pasithea Therapeutics Corp Daily Average True Range (ATR) ChartPasithea Therapeutics Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pasithea Therapeutics Corp. The current obv is 6,059,754.

Pasithea Therapeutics Corp Daily On-Balance Volume (OBV) ChartPasithea Therapeutics Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pasithea Therapeutics Corp. The current mfi is 35.41.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pasithea Therapeutics Corp Daily Money Flow Index (MFI) ChartPasithea Therapeutics Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pasithea Therapeutics Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Pasithea Therapeutics Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pasithea Therapeutics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.204
Ma 20Greater thanMa 507.252
Ma 50Greater thanMa 1007.041
Ma 100Greater thanMa 2007.036
OpenGreater thanClose7.100
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pasithea with someone you think should read this too:
  • Are you bullish or bearish on Pasithea? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pasithea? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pasithea Therapeutics Corp

I send you an email if I find something interesting about Pasithea Therapeutics Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Pasithea Therapeutics Corp.

Receive notifications about Pasithea Therapeutics Corp in your mailbox!